Follow
Meredith L. McMorrow
Title
Cited by
Cited by
Year
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
Lancet 386 (9988), 31-45, 2015
1658*2015
Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021
SJ Olsen
MMWR. Morbidity and mortality weekly report 70, 2021
4462021
Principles and practice of pediatric infectious diseases E-Book
SS Long, CG Prober, M Fischer, D Kimberlin
Elsevier Health Sciences, 2022
4312022
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
3452014
Hospitalizations associated with COVID-19 among children and adolescents—COVID-NET, 14 states, March 1, 2020–August 14, 2021
MJ Delahoy
MMWR. Morbidity and Mortality Weekly Report 70, 2021
3022021
Risk factors for severe COVID-19 in children
FHCNET 31. Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J ...
Pediatrics 149 (1), e2021053418, 2022
2352022
Malaria rapid diagnostic tests in elimination settings—can they find the last parasite?
ML McMorrow, M Aidoo, SP Kachur
Clinical Microbiology and Infection 17 (11), 1624-1631, 2011
2292011
Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 states, July 2021–January 2022
KJ Marks
MMWR. Morbidity and mortality weekly report 71, 2022
2052022
Outbreak of variant influenza A (H3N2) virus in the United States
MA Jhung, S Epperson, M Biggerstaff, D Allen, A Balish, N Barnes, ...
Clinical infectious diseases 57 (12), 1703-1712, 2013
1932013
Challenges in routine implementation and quality control of rapid diagnostic tests for malaria–Rufiji District, Tanzania
ML McMorrow, MI Masanja, SMK Abdulla, E Kahigwa, SP Kachur
The American journal of tropical medicine and hygiene 79 (3), 385, 2008
1902008
Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—nine states, January–September 2021
PJ Embi
MMWR. Morbidity and Mortality Weekly Report 70, 2021
1722021
COVID-19-associated hospitalizations among vaccinated and unvaccinated adults 18 years or older in 13 US States, January 2021 to April 2022
FP Havers, H Pham, CA Taylor, M Whitaker, K Patel, O Anglin, ...
JAMA internal medicine 182 (10), 1071-1081, 2022
1562022
Effectiveness of mRNA vaccination in preventing COVID-19–associated invasive mechanical ventilation and death—United States, March 2021–January 2022
MW Tenforde
MMWR. Morbidity and mortality weekly report 71, 2022
1512022
Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19–like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity—nine states, January …
CH Bozio
MMWR. Morbidity and Mortality Weekly Report 70, 2021
1272021
Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020
S Tempia, S Walaza, JN Bhiman, ML McMorrow, J Moyes, T Mkhencele, ...
Eurosurveillance 26 (29), 2001600, 2021
1222021
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21
C Cohen, J Kleynhans, A von Gottberg, ML McMorrow, N Wolter, ...
The Lancet Infectious Diseases 22 (6), 821-834, 2022
1202022
Effectiveness of COVID-19 mRNA vaccines against COVID-19–associated hospitalization—five veterans affairs medical centers, United States, February 1–August 6, 2021
KL Bajema
MMWR. Morbidity and Mortality Weekly Report 70, 2021
1122021
The effect of ankle stabilizers on athletic performance: a randomized prospective study
D Pienkowski, M McMorrow, R Shapiro, DNM Caborn, J Stayton
The American journal of sports medicine 23 (6), 757-762, 1995
1121995
Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices—United States, 2023
M Melgar
MMWR. Morbidity and Mortality Weekly Report 72, 2023
1062023
Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated hospitalization among immunocompetent adults aged≥ 65 years—IVY Network, 18 states …
D Surie
MMWR. Morbidity and mortality weekly report 71, 2022
982022
The system can't perform the operation now. Try again later.
Articles 1–20